BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30551455)

  • 1. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway.
    Yao Y; Zhou WY; He RX
    Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
    Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0055538 regulates the malignant biological behavior of oral squamous cell carcinoma through the p53/Bcl-2/caspase signaling pathway.
    Su W; Sun S; Wang F; Shen Y; Yang H
    J Transl Med; 2019 Mar; 17(1):76. PubMed ID: 30857544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.
    Tanaka T; Nakayama H; Yoshitake Y; Irie A; Nagata M; Kawahara K; Takamune Y; Yoshida R; Nakagawa Y; Ogi H; Shinriki S; Ota K; Hiraki A; Ikebe T; Nishimura Y; Shinohara M
    Cancer Sci; 2012 Mar; 103(3):455-63. PubMed ID: 22136381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling.
    Chang JW; Kang SU; Shin YS; Seo SJ; Kim YS; Yang SS; Lee JS; Moon E; Lee K; Kim CH
    Sci Rep; 2015 Dec; 5():18208. PubMed ID: 26655729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-Alpha Promotes Invasion and Metastasis via NF-Kappa B Pathway in Oral Squamous Cell Carcinoma.
    Tang D; Tao D; Fang Y; Deng C; Xu Q; Zhou J
    Med Sci Monit Basic Res; 2017 Apr; 23():141-149. PubMed ID: 28386055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
    Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
    Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-β1.
    Wang DG; Li TM; Liu X
    Biochem Biophys Res Commun; 2018 Sep; 503(1):86-93. PubMed ID: 29852177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.